Niveda Shekar
LightNews LightNews
banner
saltnshekar.bsky.social
Niveda Shekar
@saltnshekar.bsky.social
540 followers 570 following 2 posts
Maturing Nephron and Fellow @ NYU Langone Health, Former IM Resident @ Cook County and Rush University, Foodie 🌮🍜, Travel, and Science 🧬🔬
Posts Replies Media Videos
Reposted by Niveda Shekar
nytimes.com
The number of adults with chronic kidney disease is growing, according to a new study. The disease was the ninth leading cause of death worldwide in 2023, up from the 27th leading cause in 1990.
Rise in Kidney Disease Tied to Other Chronic Conditions, Study Finds
Rates of the disease have been rising for decades, driven in part by diabetes and high blood pressure.
nyti.ms
November 11, 2025 at 1:20 AM
Reposted by Niveda Shekar
nyunephro.bsky.social
Last week we celebrated our graduating fellows! We are so proud of you and cannot wait to see your careers flourish, congratulations! 🎓🥳✨
June 16, 2025 at 12:48 PM
Reposted by Niveda Shekar
nyunephro.bsky.social
An excellent review of kidney xenotransplantation written by the our transplant team! Check it out 🐷https://journals.lww.com/jasn/abstract/9900/xenotransplantation__current_understanding_of_the.632.aspx
Xenotransplantation: Current Understanding of the Mechanism ... : Journal of the American Society of Nephrology
this significant unmet need. Indeed, if there is a limitless supply of organs, many more patients who do not meet the current criteria for transplant eligibility could also be considered as candidates...
journals.lww.com
June 3, 2025 at 9:15 PM
Reposted by Niveda Shekar
insight.jci.org
Findings by Jennifer S. Pollock and team indicate that time-restricted feeding may be an effective intervention for improving cardiovascular and kidney health in obese mice. https://buff.ly/3EWFZYc
February 25, 2025 at 4:13 PM
Reposted by Niveda Shekar
hswapnil.medsky.social
Our last #ISNWCN debate on protein restriction in CKD is now published - #OpenAccess

pubmed.ncbi.nlm.nih.gov/39933007/

with @kidneyboy.bsky.social and Abdullah Bawazir, OttawaRenal fellow

#NephSky
Protein restriction in CKD: an outdated strategy in the modern era - PubMed
Chronic kidney disease (CKD) management has traditionally emphasized dietary protein restriction to slow disease progression and delay end-stage renal disease (ESRD). However, evidence from trials que...
pubmed.ncbi.nlm.nih.gov
February 15, 2025 at 7:42 AM
Reposted by Niveda Shekar
washingtonpost.com
The Food and Drug Administration has given two biotechnology companies approval for clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure, an experimental but potentially groundbreaking innovation.
FDA approves pig organ transplant trials for patients with kidney failure
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.
www.washingtonpost.com
February 4, 2025 at 2:27 PM
Reposted by Niveda Shekar
weddellite.bsky.social
Great imaging, not a difficult diagnosis acrobat.adobe.com/id/urn:aaid:... @nyunephro.bsky.social @saltnshekar.bsky.social
Adobe Acrobat
acrobat.adobe.com
January 28, 2025 at 11:08 PM
Reposted by Niveda Shekar
cjkhd.bsky.social
#SGLT2 inhibitors are safe and efficacious in renal #transplant recipients with #diabetes

DOI: doi.org/10.1177/2054...

@csnscn.bsky.social @cjkhd.bsky.social @UnityHealthTO
Figure 1. eGFR 24 months pre- and post-SGLT2i. eGFR ml/min/1.73m2 is shown 24 months pre- and 24 months post-SGLT2 initiation.
January 28, 2025 at 2:05 PM
Reposted by Niveda Shekar
germhuntermd.bsky.social
Scientific advancements aside, this is economically irresponsible

Every $1 spent by NIH generates $2.46

For example, in 2023, $47B in NIH spending generated ~$93B

Halting NIH spending will LOSE the US a lot of money (and talent)
An image of NIH campus. Text says : With annual budget of more than $47 billion, NIH is the largest single public funder of biomedical and behavioural research in the world. In fiscal year 2023, NIH funding generated an estimated $92.89 billion in economic activity Every state and almost every congressional district received a share of NIH investment Each year, NIH awards over 60,000 grants that directly support more than 300,000 researchers at more than 2,500 different institutions In fiscal year 2023, every $1 of NIH funding generated approximately $2.46 of economic activity
January 22, 2025 at 11:04 PM
Reposted by Niveda Shekar
hswapnil.medsky.social
A small N of 27 trial of flozins in PKD!

Already on Tolvaptan

www.kireports.org/article/S246... in @kireports.bsky.social

Hard to believe such dramatic results. But building the case for a proper RCT to be finally done!
Figure 3 Mean change in the values of (a) eGFRcr-cys, (b) eGFRcys, and (c) eGFRcr during the whole study period in groups 1 and 2 from 0 to 12 months using linear mixed models. The model included fixed effects such as group (1 or 2), period (0–12 months), and 0-month eGFR as well as an interaction term, i.e., period × group. Abbreviations: DAPA, dapagliflozin; eGFR, estimated glomerular filtration rate; cr, creatinine; cys, cystatin C.
January 18, 2025 at 1:35 PM
Reposted by Niveda Shekar
nephtimes.bsky.social
A study examined whether the use of sodium zirconium cyclosilicate combined with dialysate potassium could reduce the incidence of postdialysis atrial fibrillation and clinically significant cardiac arrhythmias. #potassium #hemodialysis #cardiovascular
SZC With Dialysate Potassium Can Reduce Arrhythmias in Hemodialysis Patients With Hyperkalemia | Docwire News
A study examined whether the use of potassium binder sodium zirconium cyclosilicate (SZC) with dialysate potassium could reduce postdialysis heart arrhythmias.
buff.ly
January 10, 2025 at 8:10 PM
Reposted by Niveda Shekar
npr.org
Only about 300 to 400 people a year give a kidney to someone they never met. It's an act of generosity so unusual, a neuroscientist studies the people who do this.
Giving a kidney to a stranger? Researchers call it 'extraordinary altruism'
Only about 300 to 400 people a year give a kidney to someone they never met. It's an act of generosity so unusual, a neuroscientist studies the people who do this.
www.npr.org
December 26, 2024 at 6:39 PM
saltnshekar.bsky.social
What an exciting time! 🐷✨ @nyunephro.bsky.social
www.npr.org/sections/sho...
A transplanted pig kidney offers a grandmother hope for life without dialysis
The patient was in kidney failure and her immune system would reject a human organ. Scientists hope genetically modified pig organs prove safe and will alleviate the organ shortage and save lives.
www.npr.org
December 17, 2024 at 3:59 PM
Reposted by Niveda Shekar
nyunephro.bsky.social
We are thrilled to be on BlueSky and more excited to introduce our 2025-2027 incoming nephrology fellows! Welcome and congratulations, we look forward to meeting you in July! ✨🎉🥳 #FellowshipMatch2024 @weddellite.bsky.social
December 5, 2024 at 4:27 AM
Reposted by Niveda Shekar
acidosistubular.bsky.social
Treating Metabolic Acidosis for CKD Progression? Need for Need for Higher Quality Data

journals.lww.com/cjasn/citati...
Treating Metabolic Acidosis for CKD Progression? Need for... : Clinical Journal of the American Society of Nephrology
An abstract is unavailable. This article is available as a PDF only.
journals.lww.com
November 28, 2024 at 8:58 PM
Reposted by Niveda Shekar
weddellite.bsky.social
www.renalandurologynews.com/news/sglt2-i... @amyaimei.bsky.social #nephsky @saltnshekar.bsky.social
SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
SGLT2 inhibitors treat type 2 diabetes and might also help prevent kidney stones.
www.renalandurologynews.com
November 27, 2024 at 2:08 AM
Reposted by Niveda Shekar
divyaveerssneph.bsky.social
🆕 Antibody identified in podocytopathies 🫘after Anti nephrin Ab⭐

Anti Slit diaphragm Ab ‼️‼️‼️

The heterogeneity in response to immunosuppression is understandable now!
#Nephsky
November 24, 2024 at 8:43 AM